Table 3. Eligible 253 Pretherapy deaths... | American Society of Hematology

Table 3.

Eligible

253

Pretherapy deaths

3

Lost to follow-up

1

Violation

2

Too early

7

Evaluable

240

CR

229 (95%)

Induction deaths

11 (5%)

Resistant disease

0

Eligible	253
Pretherapy deaths	3
Lost to follow-up	1
Violation	2
Too early	7
Evaluable	240
CR	229 (95%)
Induction deaths	11 (5%)
Resistant disease	0

This Feature Is Available To Subscribers Only

Sign In or Create an Account